Healthcare -
Biotechnology - NASDAQ - GB
$ 69.63
3.74 %
$ 737 M
Market Cap
-32.24
P/E
VRNA - STOCK-BASED COMPENSATION
Stock-based Compensation VRNA - Verona Pharma plc
19 M
LAST VALUE
-13.53%
2 YEAR CAGR
38.87%
5 YEAR CAGR
51.02%
10 YEAR CAGR